0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sofosbuvir Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-24Y11290
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Sofosbuvir Market Research Report 2022
BUY CHAPTERS

Global Sofosbuvir Market Insights, Forecast to 2030

Code: QYRE-Auto-24Y11290
Report
December 2024
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sofosbuvir Market

The report is about Sofosbuvir (CAS 1190307-88-0) API market.
The global Sofosbuvir market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Sofosbuvir is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Sofosbuvir is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Sofosbuvir is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Sofosbuvir include Teva Pharmaceutical Industries Ltd, DONG BANG FUTURE TECH & LIFE CO., LTD, Beaukev Pharma International Pvt.Ltd, DEAFARMA, Tecoland, Anhui HaiKang Pharmaceutical Co. Ltd, Shanghai Haoyuan Chemexpress Co., Ltd, Beijing Kawin Technology Share-holding Co and Hangzhou Longshine Bio-Tech Co, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Sofosbuvir production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Sofosbuvir by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Sofosbuvir, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Sofosbuvir, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Sofosbuvir, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sofosbuvir sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Sofosbuvir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Sofosbuvir sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Sofosbuvir Market Report

Report Metric Details
Report Name Sofosbuvir Market
Segment by Type
  • Purity ≥ 98%
  • Purity < 98%
Segment by Application
  • Adults Patients
  • Elderly Patients
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teva Pharmaceutical Industries Ltd, DONG BANG FUTURE TECH & LIFE CO., LTD, Beaukev Pharma International Pvt.Ltd, DEAFARMA, Tecoland, Anhui HaiKang Pharmaceutical Co. Ltd, Shanghai Haoyuan Chemexpress Co., Ltd, Beijing Kawin Technology Share-holding Co, Hangzhou Longshine Bio-Tech Co
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sofosbuvir production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
  • Chapter 3: Sales (consumption), revenue of Sofosbuvir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 4: Detailed analysis of Sofosbuvir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sofosbuvir sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 15: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sofosbuvir Market report?

Ans: The main players in the Sofosbuvir Market are Teva Pharmaceutical Industries Ltd, DONG BANG FUTURE TECH & LIFE CO., LTD, Beaukev Pharma International Pvt.Ltd, DEAFARMA, Tecoland, Anhui HaiKang Pharmaceutical Co. Ltd, Shanghai Haoyuan Chemexpress Co., Ltd, Beijing Kawin Technology Share-holding Co, Hangzhou Longshine Bio-Tech Co

What are the Application segmentation covered in the Sofosbuvir Market report?

Ans: The Applications covered in the Sofosbuvir Market report are Adults Patients, Elderly Patients

What are the Type segmentation covered in the Sofosbuvir Market report?

Ans: The Types covered in the Sofosbuvir Market report are Purity ≥ 98%, Purity < 98%

Recommended Reports

API Market Reports

Antiviral & Hepatitis

Virus Diagnostics

1 Study Coverage
1.1 Sofosbuvir Product Introduction
1.2 Market by Type
1.2.1 Global Sofosbuvir Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Purity ≥ 98%
1.2.3 Purity < 98%
1.3 Market by Application
1.3.1 Global Sofosbuvir Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Adults Patients
1.3.3 Elderly Patients
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Sofosbuvir Production
2.1 Global Sofosbuvir Production Capacity (2019-2030)
2.2 Global Sofosbuvir Production by Region: 2019 VS 2023 VS 2030
2.3 Global Sofosbuvir Production by Region
2.3.1 Global Sofosbuvir Historic Production by Region (2019-2024)
2.3.2 Global Sofosbuvir Forecasted Production by Region (2025-2030)
2.3.3 Global Sofosbuvir Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Sofosbuvir Revenue Estimates and Forecasts 2019-2030
3.2 Global Sofosbuvir Revenue by Region
3.2.1 Global Sofosbuvir Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Sofosbuvir Revenue by Region (2019-2024)
3.2.3 Global Sofosbuvir Revenue by Region (2025-2030)
3.2.4 Global Sofosbuvir Revenue Market Share by Region (2019-2030)
3.3 Global Sofosbuvir Sales Estimates and Forecasts 2019-2030
3.4 Global Sofosbuvir Sales by Region
3.4.1 Global Sofosbuvir Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Sofosbuvir Sales by Region (2019-2024)
3.4.3 Global Sofosbuvir Sales by Region (2025-2030)
3.4.4 Global Sofosbuvir Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Sofosbuvir Sales by Manufacturers
4.1.1 Global Sofosbuvir Sales by Manufacturers (2019-2024)
4.1.2 Global Sofosbuvir Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sofosbuvir in 2023
4.2 Global Sofosbuvir Revenue by Manufacturers
4.2.1 Global Sofosbuvir Revenue by Manufacturers (2019-2024)
4.2.2 Global Sofosbuvir Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Sofosbuvir Revenue in 2023
4.3 Global Sofosbuvir Sales Price by Manufacturers
4.4 Global Key Players of Sofosbuvir, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Sofosbuvir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Sofosbuvir, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Sofosbuvir, Product Offered and Application
4.8 Global Key Manufacturers of Sofosbuvir, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Sofosbuvir Sales by Type
5.1.1 Global Sofosbuvir Historical Sales by Type (2019-2024)
5.1.2 Global Sofosbuvir Forecasted Sales by Type (2025-2030)
5.1.3 Global Sofosbuvir Sales Market Share by Type (2019-2030)
5.2 Global Sofosbuvir Revenue by Type
5.2.1 Global Sofosbuvir Historical Revenue by Type (2019-2024)
5.2.2 Global Sofosbuvir Forecasted Revenue by Type (2025-2030)
5.2.3 Global Sofosbuvir Revenue Market Share by Type (2019-2030)
5.3 Global Sofosbuvir Price by Type
5.3.1 Global Sofosbuvir Price by Type (2019-2024)
5.3.2 Global Sofosbuvir Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Sofosbuvir Sales by Application
6.1.1 Global Sofosbuvir Historical Sales by Application (2019-2024)
6.1.2 Global Sofosbuvir Forecasted Sales by Application (2025-2030)
6.1.3 Global Sofosbuvir Sales Market Share by Application (2019-2030)
6.2 Global Sofosbuvir Revenue by Application
6.2.1 Global Sofosbuvir Historical Revenue by Application (2019-2024)
6.2.2 Global Sofosbuvir Forecasted Revenue by Application (2025-2030)
6.2.3 Global Sofosbuvir Revenue Market Share by Application (2019-2030)
6.3 Global Sofosbuvir Price by Application
6.3.1 Global Sofosbuvir Price by Application (2019-2024)
6.3.2 Global Sofosbuvir Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Sofosbuvir Market Size by Type
7.1.1 US & Canada Sofosbuvir Sales by Type (2019-2030)
7.1.2 US & Canada Sofosbuvir Revenue by Type (2019-2030)
7.2 US & Canada Sofosbuvir Market Size by Application
7.2.1 US & Canada Sofosbuvir Sales by Application (2019-2030)
7.2.2 US & Canada Sofosbuvir Revenue by Application (2019-2030)
7.3 US & Canada Sofosbuvir Sales by Country
7.3.1 US & Canada Sofosbuvir Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Sofosbuvir Sales by Country (2019-2030)
7.3.3 US & Canada Sofosbuvir Revenue by Country (2019-2030)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Sofosbuvir Market Size by Type
8.1.1 Europe Sofosbuvir Sales by Type (2019-2030)
8.1.2 Europe Sofosbuvir Revenue by Type (2019-2030)
8.2 Europe Sofosbuvir Market Size by Application
8.2.1 Europe Sofosbuvir Sales by Application (2019-2030)
8.2.2 Europe Sofosbuvir Revenue by Application (2019-2030)
8.3 Europe Sofosbuvir Sales by Country
8.3.1 Europe Sofosbuvir Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Sofosbuvir Sales by Country (2019-2030)
8.3.3 Europe Sofosbuvir Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Sofosbuvir Market Size by Type
9.1.1 China Sofosbuvir Sales by Type (2019-2030)
9.1.2 China Sofosbuvir Revenue by Type (2019-2030)
9.2 China Sofosbuvir Market Size by Application
9.2.1 China Sofosbuvir Sales by Application (2019-2030)
9.2.2 China Sofosbuvir Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Sofosbuvir Market Size by Type
10.1.1 Asia Sofosbuvir Sales by Type (2019-2030)
10.1.2 Asia Sofosbuvir Revenue by Type (2019-2030)
10.2 Asia Sofosbuvir Market Size by Application
10.2.1 Asia Sofosbuvir Sales by Application (2019-2030)
10.2.2 Asia Sofosbuvir Revenue by Application (2019-2030)
10.3 Asia Sofosbuvir Sales by Region
10.3.1 Asia Sofosbuvir Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Sofosbuvir Revenue by Region (2019-2030)
10.3.3 Asia Sofosbuvir Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Sofosbuvir Market Size by Type
11.1.1 Middle East, Africa and Latin America Sofosbuvir Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Sofosbuvir Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Sofosbuvir Market Size by Application
11.2.1 Middle East, Africa and Latin America Sofosbuvir Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Sofosbuvir Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Sofosbuvir Sales by Country
11.3.1 Middle East, Africa and Latin America Sofosbuvir Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Sofosbuvir Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Sofosbuvir Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Teva Pharmaceutical Industries Ltd
12.1.1 Teva Pharmaceutical Industries Ltd Company Information
12.1.2 Teva Pharmaceutical Industries Ltd Overview
12.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Teva Pharmaceutical Industries Ltd Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
12.2 DONG BANG FUTURE TECH & LIFE CO., LTD
12.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Company Information
12.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Overview
12.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Recent Developments
12.3 Beaukev Pharma International Pvt.Ltd
12.3.1 Beaukev Pharma International Pvt.Ltd Company Information
12.3.2 Beaukev Pharma International Pvt.Ltd Overview
12.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Beaukev Pharma International Pvt.Ltd Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Beaukev Pharma International Pvt.Ltd Recent Developments
12.4 DEAFARMA
12.4.1 DEAFARMA Company Information
12.4.2 DEAFARMA Overview
12.4.3 DEAFARMA Sofosbuvir Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 DEAFARMA Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 DEAFARMA Recent Developments
12.5 Tecoland
12.5.1 Tecoland Company Information
12.5.2 Tecoland Overview
12.5.3 Tecoland Sofosbuvir Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Tecoland Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Tecoland Recent Developments
12.6 Anhui HaiKang Pharmaceutical Co. Ltd
12.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Company Information
12.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Overview
12.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Anhui HaiKang Pharmaceutical Co. Ltd Recent Developments
12.7 Shanghai Haoyuan Chemexpress Co., Ltd
12.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Company Information
12.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Overview
12.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Shanghai Haoyuan Chemexpress Co., Ltd Recent Developments
12.8 Beijing Kawin Technology Share-holding Co
12.8.1 Beijing Kawin Technology Share-holding Co Company Information
12.8.2 Beijing Kawin Technology Share-holding Co Overview
12.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.8.4 Beijing Kawin Technology Share-holding Co Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Beijing Kawin Technology Share-holding Co Recent Developments
12.9 Hangzhou Longshine Bio-Tech Co
12.9.1 Hangzhou Longshine Bio-Tech Co Company Information
12.9.2 Hangzhou Longshine Bio-Tech Co Overview
12.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.9.4 Hangzhou Longshine Bio-Tech Co Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Hangzhou Longshine Bio-Tech Co Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Sofosbuvir Industry Chain Analysis
13.2 Sofosbuvir Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Sofosbuvir Production Mode & Process
13.4 Sofosbuvir Sales and Marketing
13.4.1 Sofosbuvir Sales Channels
13.4.2 Sofosbuvir Distributors
13.5 Sofosbuvir Customers
14 Sofosbuvir Market Dynamics
14.1 Sofosbuvir Industry Trends
14.2 Sofosbuvir Market Drivers
14.3 Sofosbuvir Market Challenges
14.4 Sofosbuvir Market Restraints
15 Key Finding in The Global Sofosbuvir Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Sofosbuvir Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Purity ≥ 98%
    Table 3. Major Manufacturers of Purity < 98%
    Table 4. Global Sofosbuvir Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Sofosbuvir Production by Region: 2019 VS 2023 VS 2030 (MT)
    Table 6. Global Sofosbuvir Production by Region (2019-2024) & (MT)
    Table 7. Global Sofosbuvir Production by Region (2025-2030) & (MT)
    Table 8. Global Sofosbuvir Production Market Share by Region (2019-2024)
    Table 9. Global Sofosbuvir Production Market Share by Region (2025-2030)
    Table 10. Global Sofosbuvir Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Sofosbuvir Revenue by Region (2019-2024) & (US$ Million)
    Table 12. Global Sofosbuvir Revenue by Region (2025-2030) & (US$ Million)
    Table 13. Global Sofosbuvir Revenue Market Share by Region (2019-2024)
    Table 14. Global Sofosbuvir Revenue Market Share by Region (2025-2030)
    Table 15. Global Sofosbuvir Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 16. Global Sofosbuvir Sales by Region (2019-2024) & (MT)
    Table 17. Global Sofosbuvir Sales by Region (2025-2030) & (MT)
    Table 18. Global Sofosbuvir Sales Market Share by Region (2019-2024)
    Table 19. Global Sofosbuvir Sales Market Share by Region (2025-2030)
    Table 20. Global Sofosbuvir Sales by Manufacturers (2019-2024) & (MT)
    Table 21. Global Sofosbuvir Sales Share by Manufacturers (2019-2024)
    Table 22. Global Sofosbuvir Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 23. Global Sofosbuvir Revenue Share by Manufacturers (2019-2024)
    Table 24. Sofosbuvir Price by Manufacturers 2019-2024 (USD/MT)
    Table 25. Global Key Players of Sofosbuvir, Industry Ranking, 2022 VS 2023 VS 2024
    Table 26. Global Sofosbuvir Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Sofosbuvir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sofosbuvir as of 2023)
    Table 28. Global Key Manufacturers of Sofosbuvir, Manufacturing Base Distribution and Headquarters
    Table 29. Global Key Manufacturers of Sofosbuvir, Product Offered and Application
    Table 30. Global Key Manufacturers of Sofosbuvir, Date of Enter into This Industry
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Sofosbuvir Sales by Type (2019-2024) & (MT)
    Table 33. Global Sofosbuvir Sales by Type (2025-2030) & (MT)
    Table 34. Global Sofosbuvir Sales Share by Type (2019-2024)
    Table 35. Global Sofosbuvir Sales Share by Type (2025-2030)
    Table 36. Global Sofosbuvir Revenue by Type (2019-2024) & (US$ Million)
    Table 37. Global Sofosbuvir Revenue by Type (2025-2030) & (US$ Million)
    Table 38. Global Sofosbuvir Revenue Share by Type (2019-2024)
    Table 39. Global Sofosbuvir Revenue Share by Type (2025-2030)
    Table 40. Sofosbuvir Price by Type (2019-2024) & (USD/MT)
    Table 41. Global Sofosbuvir Price Forecast by Type (2025-2030) & (USD/MT)
    Table 42. Global Sofosbuvir Sales by Application (2019-2024) & (MT)
    Table 43. Global Sofosbuvir Sales by Application (2025-2030) & (MT)
    Table 44. Global Sofosbuvir Sales Share by Application (2019-2024)
    Table 45. Global Sofosbuvir Sales Share by Application (2025-2030)
    Table 46. Global Sofosbuvir Revenue by Application (2019-2024) & (US$ Million)
    Table 47. Global Sofosbuvir Revenue by Application (2025-2030) & (US$ Million)
    Table 48. Global Sofosbuvir Revenue Share by Application (2019-2024)
    Table 49. Global Sofosbuvir Revenue Share by Application (2025-2030)
    Table 50. Sofosbuvir Price by Application (2019-2024) & (USD/MT)
    Table 51. Global Sofosbuvir Price Forecast by Application (2025-2030) & (USD/MT)
    Table 52. US & Canada Sofosbuvir Sales by Type (2019-2024) & (MT)
    Table 53. US & Canada Sofosbuvir Sales by Type (2025-2030) & (MT)
    Table 54. US & Canada Sofosbuvir Revenue by Type (2019-2024) & (US$ Million)
    Table 55. US & Canada Sofosbuvir Revenue by Type (2025-2030) & (US$ Million)
    Table 56. US & Canada Sofosbuvir Sales by Application (2019-2024) & (MT)
    Table 57. US & Canada Sofosbuvir Sales by Application (2025-2030) & (MT)
    Table 58. US & Canada Sofosbuvir Revenue by Application (2019-2024) & (US$ Million)
    Table 59. US & Canada Sofosbuvir Revenue by Application (2025-2030) & (US$ Million)
    Table 60. US & Canada Sofosbuvir Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 61. US & Canada Sofosbuvir Revenue by Country (2019-2024) & (US$ Million)
    Table 62. US & Canada Sofosbuvir Revenue by Country (2025-2030) & (US$ Million)
    Table 63. US & Canada Sofosbuvir Sales by Country (2019-2024) & (MT)
    Table 64. US & Canada Sofosbuvir Sales by Country (2025-2030) & (MT)
    Table 65. Europe Sofosbuvir Sales by Type (2019-2024) & (MT)
    Table 66. Europe Sofosbuvir Sales by Type (2025-2030) & (MT)
    Table 67. Europe Sofosbuvir Revenue by Type (2019-2024) & (US$ Million)
    Table 68. Europe Sofosbuvir Revenue by Type (2025-2030) & (US$ Million)
    Table 69. Europe Sofosbuvir Sales by Application (2019-2024) & (MT)
    Table 70. Europe Sofosbuvir Sales by Application (2025-2030) & (MT)
    Table 71. Europe Sofosbuvir Revenue by Application (2019-2024) & (US$ Million)
    Table 72. Europe Sofosbuvir Revenue by Application (2025-2030) & (US$ Million)
    Table 73. Europe Sofosbuvir Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 74. Europe Sofosbuvir Revenue by Country (2019-2024) & (US$ Million)
    Table 75. Europe Sofosbuvir Revenue by Country (2025-2030) & (US$ Million)
    Table 76. Europe Sofosbuvir Sales by Country (2019-2024) & (MT)
    Table 77. Europe Sofosbuvir Sales by Country (2025-2030) & (MT)
    Table 78. China Sofosbuvir Sales by Type (2019-2024) & (MT)
    Table 79. China Sofosbuvir Sales by Type (2025-2030) & (MT)
    Table 80. China Sofosbuvir Revenue by Type (2019-2024) & (US$ Million)
    Table 81. China Sofosbuvir Revenue by Type (2025-2030) & (US$ Million)
    Table 82. China Sofosbuvir Sales by Application (2019-2024) & (MT)
    Table 83. China Sofosbuvir Sales by Application (2025-2030) & (MT)
    Table 84. China Sofosbuvir Revenue by Application (2019-2024) & (US$ Million)
    Table 85. China Sofosbuvir Revenue by Application (2025-2030) & (US$ Million)
    Table 86. Asia Sofosbuvir Sales by Type (2019-2024) & (MT)
    Table 87. Asia Sofosbuvir Sales by Type (2025-2030) & (MT)
    Table 88. Asia Sofosbuvir Revenue by Type (2019-2024) & (US$ Million)
    Table 89. Asia Sofosbuvir Revenue by Type (2025-2030) & (US$ Million)
    Table 90. Asia Sofosbuvir Sales by Application (2019-2024) & (MT)
    Table 91. Asia Sofosbuvir Sales by Application (2025-2030) & (MT)
    Table 92. Asia Sofosbuvir Revenue by Application (2019-2024) & (US$ Million)
    Table 93. Asia Sofosbuvir Revenue by Application (2025-2030) & (US$ Million)
    Table 94. Asia Sofosbuvir Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 95. Asia Sofosbuvir Revenue by Region (2019-2024) & (US$ Million)
    Table 96. Asia Sofosbuvir Revenue by Region (2025-2030) & (US$ Million)
    Table 97. Asia Sofosbuvir Sales by Region (2019-2024) & (MT)
    Table 98. Asia Sofosbuvir Sales by Region (2025-2030) & (MT)
    Table 99. Middle East, Africa and Latin America Sofosbuvir Sales by Type (2019-2024) & (MT)
    Table 100. Middle East, Africa and Latin America Sofosbuvir Sales by Type (2025-2030) & (MT)
    Table 101. Middle East, Africa and Latin America Sofosbuvir Revenue by Type (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Sofosbuvir Revenue by Type (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Sofosbuvir Sales by Application (2019-2024) & (MT)
    Table 104. Middle East, Africa and Latin America Sofosbuvir Sales by Application (2025-2030) & (MT)
    Table 105. Middle East, Africa and Latin America Sofosbuvir Revenue by Application (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Sofosbuvir Revenue by Application (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Sofosbuvir Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 108. Middle East, Africa and Latin America Sofosbuvir Revenue by Country (2019-2024) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Sofosbuvir Revenue by Country (2025-2030) & (US$ Million)
    Table 110. Middle East, Africa and Latin America Sofosbuvir Sales by Country (2019-2024) & (MT)
    Table 111. Middle East, Africa and Latin America Sofosbuvir Sales by Country (2025-2030) & (MT)
    Table 112. Teva Pharmaceutical Industries Ltd Company Information
    Table 113. Teva Pharmaceutical Industries Ltd Description and Major Businesses
    Table 114. Teva Pharmaceutical Industries Ltd Sofosbuvir Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 115. Teva Pharmaceutical Industries Ltd Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Teva Pharmaceutical Industries Ltd Recent Development
    Table 117. DONG BANG FUTURE TECH & LIFE CO., LTD Company Information
    Table 118. DONG BANG FUTURE TECH & LIFE CO., LTD Description and Major Businesses
    Table 119. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 120. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. DONG BANG FUTURE TECH & LIFE CO., LTD Recent Development
    Table 122. Beaukev Pharma International Pvt.Ltd Company Information
    Table 123. Beaukev Pharma International Pvt.Ltd Description and Major Businesses
    Table 124. Beaukev Pharma International Pvt.Ltd Sofosbuvir Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 125. Beaukev Pharma International Pvt.Ltd Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Beaukev Pharma International Pvt.Ltd Recent Development
    Table 127. DEAFARMA Company Information
    Table 128. DEAFARMA Description and Major Businesses
    Table 129. DEAFARMA Sofosbuvir Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 130. DEAFARMA Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. DEAFARMA Recent Development
    Table 132. Tecoland Company Information
    Table 133. Tecoland Description and Major Businesses
    Table 134. Tecoland Sofosbuvir Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 135. Tecoland Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Tecoland Recent Development
    Table 137. Anhui HaiKang Pharmaceutical Co. Ltd Company Information
    Table 138. Anhui HaiKang Pharmaceutical Co. Ltd Description and Major Businesses
    Table 139. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 140. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Anhui HaiKang Pharmaceutical Co. Ltd Recent Development
    Table 142. Shanghai Haoyuan Chemexpress Co., Ltd Company Information
    Table 143. Shanghai Haoyuan Chemexpress Co., Ltd Description and Major Businesses
    Table 144. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 145. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Shanghai Haoyuan Chemexpress Co., Ltd Recent Development
    Table 147. Beijing Kawin Technology Share-holding Co Company Information
    Table 148. Beijing Kawin Technology Share-holding Co Description and Major Businesses
    Table 149. Beijing Kawin Technology Share-holding Co Sofosbuvir Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 150. Beijing Kawin Technology Share-holding Co Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Beijing Kawin Technology Share-holding Co Recent Development
    Table 152. Hangzhou Longshine Bio-Tech Co Company Information
    Table 153. Hangzhou Longshine Bio-Tech Co Description and Major Businesses
    Table 154. Hangzhou Longshine Bio-Tech Co Sofosbuvir Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 155. Hangzhou Longshine Bio-Tech Co Sofosbuvir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Hangzhou Longshine Bio-Tech Co Recent Development
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Sofosbuvir Distributors List
    Table 160. Sofosbuvir Customers List
    Table 161. Sofosbuvir Market Trends
    Table 162. Sofosbuvir Market Drivers
    Table 163. Sofosbuvir Market Challenges
    Table 164. Sofosbuvir Market Restraints
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sofosbuvir Product Picture
    Figure 2. Global Sofosbuvir Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Sofosbuvir Market Share by Type in 2023 & 2030
    Figure 4. Purity ≥ 98% Product Picture
    Figure 5. Purity < 98% Product Picture
    Figure 6. Global Sofosbuvir Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Sofosbuvir Market Share by Application in 2023 & 2030
    Figure 8. Adults Patients
    Figure 9. Elderly Patients
    Figure 10. Sofosbuvir Report Years Considered
    Figure 11. Global Sofosbuvir Capacity, Production and Utilization (2019-2030) & (MT)
    Figure 12. Global Sofosbuvir Production Market Share by Region in Percentage: 2023 Versus 2030
    Figure 13. Global Sofosbuvir Production Market Share by Region (2019-2030)
    Figure 14. Sofosbuvir Production Growth Rate in North America (2019-2030) & (MT)
    Figure 15. Sofosbuvir Production Growth Rate in Europe (2019-2030) & (MT)
    Figure 16. Sofosbuvir Production Growth Rate in China (2019-2030) & (MT)
    Figure 17. Sofosbuvir Production Growth Rate in Japan (2019-2030) & (MT)
    Figure 18. Global Sofosbuvir Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Sofosbuvir Revenue 2019-2030 (US$ Million)
    Figure 20. Global Sofosbuvir Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Figure 21. Global Sofosbuvir Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 22. Global Sofosbuvir Revenue Market Share by Region (2019-2030)
    Figure 23. Global Sofosbuvir Sales 2019-2030 ((MT)
    Figure 24. Global Sofosbuvir Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (MT)
    Figure 25. Global Sofosbuvir Sales Market Share by Region (2019-2030)
    Figure 26. US & Canada Sofosbuvir Sales YoY (2019-2030) & (MT)
    Figure 27. US & Canada Sofosbuvir Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Sofosbuvir Sales YoY (2019-2030) & (MT)
    Figure 29. Europe Sofosbuvir Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. China Sofosbuvir Sales YoY (2019-2030) & (MT)
    Figure 31. China Sofosbuvir Revenue YoY (2019-2030) & (US$ Million)
    Figure 32. Asia (excluding China) Sofosbuvir Sales YoY (2019-2030) & (MT)
    Figure 33. Asia (excluding China) Sofosbuvir Revenue YoY (2019-2030) & (US$ Million)
    Figure 34. Middle East, Africa and Latin America Sofosbuvir Sales YoY (2019-2030) & (MT)
    Figure 35. Middle East, Africa and Latin America Sofosbuvir Revenue YoY (2019-2030) & (US$ Million)
    Figure 36. The Sofosbuvir Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 37. The Top 5 and 10 Largest Manufacturers of Sofosbuvir in the World: Market Share by Sofosbuvir Revenue in 2023
    Figure 38. Global Sofosbuvir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 39. Global Sofosbuvir Sales Market Share by Type (2019-2030)
    Figure 40. Global Sofosbuvir Revenue Market Share by Type (2019-2030)
    Figure 41. Global Sofosbuvir Sales Market Share by Application (2019-2030)
    Figure 42. Global Sofosbuvir Revenue Market Share by Application (2019-2030)
    Figure 43. US & Canada Sofosbuvir Sales Market Share by Type (2019-2030)
    Figure 44. US & Canada Sofosbuvir Revenue Market Share by Type (2019-2030)
    Figure 45. US & Canada Sofosbuvir Sales Market Share by Application (2019-2030)
    Figure 46. US & Canada Sofosbuvir Revenue Market Share by Application (2019-2030)
    Figure 47. US & Canada Sofosbuvir Revenue Share by Country (2019-2030)
    Figure 48. US & Canada Sofosbuvir Sales Share by Country (2019-2030)
    Figure 49. U.S. Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 50. Canada Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 51. Europe Sofosbuvir Sales Market Share by Type (2019-2030)
    Figure 52. Europe Sofosbuvir Revenue Market Share by Type (2019-2030)
    Figure 53. Europe Sofosbuvir Sales Market Share by Application (2019-2030)
    Figure 54. Europe Sofosbuvir Revenue Market Share by Application (2019-2030)
    Figure 55. Europe Sofosbuvir Revenue Share by Country (2019-2030)
    Figure 56. Europe Sofosbuvir Sales Share by Country (2019-2030)
    Figure 57. Germany Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 58. France Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 59. U.K. Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 60. Italy Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 61. Russia Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 62. China Sofosbuvir Sales Market Share by Type (2019-2030)
    Figure 63. China Sofosbuvir Revenue Market Share by Type (2019-2030)
    Figure 64. China Sofosbuvir Sales Market Share by Application (2019-2030)
    Figure 65. China Sofosbuvir Revenue Market Share by Application (2019-2030)
    Figure 66. Asia Sofosbuvir Sales Market Share by Type (2019-2030)
    Figure 67. Asia Sofosbuvir Revenue Market Share by Type (2019-2030)
    Figure 68. Asia Sofosbuvir Sales Market Share by Application (2019-2030)
    Figure 69. Asia Sofosbuvir Revenue Market Share by Application (2019-2030)
    Figure 70. Asia Sofosbuvir Revenue Share by Region (2019-2030)
    Figure 71. Asia Sofosbuvir Sales Share by Region (2019-2030)
    Figure 72. Japan Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 73. South Korea Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 74. China Taiwan Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 75. Southeast Asia Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 76. India Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 77. Middle East, Africa and Latin America Sofosbuvir Sales Market Share by Type (2019-2030)
    Figure 78. Middle East, Africa and Latin America Sofosbuvir Revenue Market Share by Type (2019-2030)
    Figure 79. Middle East, Africa and Latin America Sofosbuvir Sales Market Share by Application (2019-2030)
    Figure 80. Middle East, Africa and Latin America Sofosbuvir Revenue Market Share by Application (2019-2030)
    Figure 81. Middle East, Africa and Latin America Sofosbuvir Revenue Share by Country (2019-2030)
    Figure 82. Middle East, Africa and Latin America Sofosbuvir Sales Share by Country (2019-2030)
    Figure 83. Brazil Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 84. Mexico Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 85. Turkey Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 86. Israel Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 87. GCC Countries Sofosbuvir Revenue (2019-2030) & (US$ Million)
    Figure 88. Sofosbuvir Value Chain
    Figure 89. Sofosbuvir Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Nano Porous Silicon–carbon Anode Material Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0F17509
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Foam Board Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16F19834
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Copper Wires Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5U6954
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Quartz Fiber Cloth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20G17359
Fri Sep 12 00:00:00 UTC 2025

Add to Cart